Case report and review of the literature: Secretory breast cancer in a 13-year-old boy—10 years of follow up
Beyond taxanes: the next generation of microtubule-targeting agents
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer
Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?
Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression
Investigation of human JC and BK polyomaviruses in breast carcinomas
A CD44-/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells
Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial
25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1
Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES)
Family history and risk of breast cancer: nurses' health study
Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study
Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study
Benign thyroid disease is associated with breast cancer: a meta-analysis
Rare germline large rearrangements in the BRCA1 / 2 genes and eight candidate genes in 472 patients with breast cancer predisposition
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy